Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer-A population-based cohort study.

Rano Matta Amanda E HirdErind DvoraniRefik SaskinGregory J NasonGirish KulkarniRonald T KodamaSender HerschornRobert K Nam

Published in: Cancer medicine (2020)

Among patients with localized prostate cancer on AS, one third undergo DT. The rate of secondary treatment was similar between the DT and IT groups. Patients in the DT group may experience a higher risk of mortality compared to those who remained on AS.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
radical prostatectomy
cardiovascular disease
cardiovascular events
patient reported outcomes